This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AMDA vs. MGRM, NSPR, SRTS, ICCM, CTSO, INO, MBOT, GUTS, ICAD, and TMDIFShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include Monogram Orthopaedics (MGRM), InspireMD (NSPR), Sensus Healthcare (SRTS), IceCure Medical (ICCM), Cytosorbents (CTSO), Inovio Pharmaceuticals (INO), Microbot Medical (MBOT), Fractyl Health (GUTS), iCAD (ICAD), and Titan Medical (TMDIF). Amedica vs. Monogram Orthopaedics InspireMD Sensus Healthcare IceCure Medical Cytosorbents Inovio Pharmaceuticals Microbot Medical Fractyl Health iCAD Titan Medical Amedica (NASDAQ:AMDA) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability, media sentiment, community ranking and analyst recommendations. Does the MarketBeat Community favor AMDA or MGRM? Amedica received 304 more outperform votes than Monogram Orthopaedics when rated by MarketBeat users. However, 75.00% of users gave Monogram Orthopaedics an outperform vote while only 64.90% of users gave Amedica an outperform vote. CompanyUnderperformOutperformAmedicaOutperform Votes30764.90% Underperform Votes16635.10% Monogram OrthopaedicsOutperform Votes375.00% Underperform Votes125.00% Is AMDA or MGRM more profitable? Monogram Orthopaedics has a net margin of 0.00% compared to Amedica's net margin of -139.62%. Monogram Orthopaedics' return on equity of -130.90% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets Amedica-139.62% -148.60% -67.83% Monogram Orthopaedics N/A -130.90%-106.38% Do analysts rate AMDA or MGRM? Monogram Orthopaedics has a consensus target price of $5.40, indicating a potential upside of 100.00%. Given Monogram Orthopaedics' stronger consensus rating and higher probable upside, analysts plainly believe Monogram Orthopaedics is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Does the media favor AMDA or MGRM? In the previous week, Monogram Orthopaedics had 11 more articles in the media than Amedica. MarketBeat recorded 11 mentions for Monogram Orthopaedics and 0 mentions for Amedica. Amedica's average media sentiment score of 0.00 beat Monogram Orthopaedics' score of -0.08 indicating that Amedica is being referred to more favorably in the media. Company Overall Sentiment Amedica Neutral Monogram Orthopaedics Neutral Do institutionals & insiders have more ownership in AMDA or MGRM? 3.7% of Amedica shares are held by institutional investors. Comparatively, 0.4% of Monogram Orthopaedics shares are held by institutional investors. 0.9% of Amedica shares are held by insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, AMDA or MGRM? Amedica has a beta of -1.24, indicating that its share price is 224% less volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Which has preferable valuation and earnings, AMDA or MGRM? Amedica has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Amedica, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedica$11.23M1.85-$9.32M-$3.13-0.56Monogram Orthopaedics$365.00K261.04-$13.74M-$0.46-5.87 SummaryMonogram Orthopaedics beats Amedica on 12 of the 19 factors compared between the two stocks. Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.77M$4.07B$5.31B$7.35BDividend YieldN/A46.44%5.47%4.31%P/E Ratio-0.5628.0921.9417.82Price / Sales1.8547.06380.9497.68Price / CashN/A51.0838.3134.64Price / Book0.975.816.453.98Net Income-$9.32M$67.09M$3.22B$247.81M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$1.75+1.2%N/A+4,086.6%$20.77M$11.23M-0.56N/AMGRMMonogram Orthopaedics2.329 of 5 stars$2.49+4.2%$5.40+116.9%+20.0%$87.87M$364,999.00-5.3028Short Interest ↑Analyst RevisionNews CoverageGap DownNSPRInspireMD2.1151 of 5 stars$2.60-2.6%$4.75+82.7%+23.9%$77.19M$7.01M-3.4750Analyst ForecastSRTSSensus Healthcare2.5723 of 5 stars$4.59+0.4%$13.00+183.2%+39.5%$75.71M$41.81M11.4840ICCMIceCure Medical1.7407 of 5 stars$1.14+6.5%$2.50+119.3%-7.0%$63.27M$3.29M-3.9360Gap DownCTSOCytosorbents1.7612 of 5 stars$0.94-2.1%$4.67+396.5%+28.4%$58.75M$35.59M-2.61220Analyst ForecastINOInovio Pharmaceuticals3.1754 of 5 stars$1.59+8.9%$12.20+667.3%-82.0%$58.30M$217,756.00-0.40320Analyst UpgradeShort Interest ↑Negative NewsMBOTMicrobot Medical1.9822 of 5 stars$1.65+18.7%$9.00+445.5%+187.9%$57.33MN/A-2.0620High Trading VolumeGUTSFractyl Health1.7197 of 5 stars$1.00-6.6%$10.00+900.1%-81.4%$48.92M$93,000.00-0.08102Analyst ForecastNews CoverageGap DownHigh Trading VolumeICADiCAD0.3284 of 5 stars$1.76+6.0%N/A+109.1%$48.16M$19.61M-13.54140Analyst DowngradeShort Interest ↑News CoverageGap UpTMDIFTitan MedicalN/A$0.42+7.0%N/A+793.8%$47.97M$17.63M-0.3450Gap Up Related Companies and Tools Related Companies Monogram Orthopaedics Competitors InspireMD Competitors Sensus Healthcare Competitors IceCure Medical Competitors Cytosorbents Competitors Inovio Pharmaceuticals Competitors Microbot Medical Competitors Fractyl Health Competitors iCAD Competitors Titan Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMDA) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMDA Stock Free AMDA Stock Alerts